Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Subsequent Events

v3.19.3
Note 7 - Subsequent Events
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Subsequent Events [Text Block]
Note
7.
  Subsequent Events
Effective
October 28, 2019,
the Company filed an amendment to it amended and restated certificate of incorporation changing the Company’s name from Neuralstem, Inc. to Seneca Biopharma, Inc.